Catalyst Funds Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,290	Closed	-$19.9K	–	1525
2024 Q1	$19.9K	Buy	+4,290	New	+$19.9K	0.01%	760